Clinical Efficacy of OneTouch® Verio™IQ Meter

Diabetes mellitus is one of the most prevalent disease in the western world. The control of glucose levels has a big impact in the prevention of diabetes complications. The measure of glucose levels in capillary blood with glucometers is the gold standard to measure and control the glucose levels. Nowadays the glucometers become to more precise and sophisticated devices. One of the most notables advance is the inclusion of software that cam predicts glucose trends. This software has not be tested in routine clinical practice.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Complejo Hospitalario Universitario A Coruña, A Coruña, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient diagnosed with diabetes mellitus 1 or 2
Treatment with insulin regimen during at least 12 months
Capability of performed 3 glucose measurement per day
Levels of glycated hemoglobin (A1C) less than 10%

Exclusion criteria

Patients diagnosed of mental disorders
Patients included in structured therapeutic health 6 months before the inclusion
Patients included in any clinical trial in the 4 months before the inclusion

Treatment and study plan

Verio Pattern Alert® activated

Device

Verio Pattern Alert® deactivated

Device

Primary outcomes

number of hypoglycemic events

Time frame: 20 months

Glucose levels under 70 mg/dL with or without clinical manifestation

Sponsors and collaborators

Lead sponsor

Fundación Pública Andaluza Progreso y Salud

Other

Registry information

Acronym: ECOVIQ

Important dates

Study start: 2015
Primary completion: 2016
Study completion: 2016
First posted: Aug 13, 2015
Registry last updated: Mar 7, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed